Exosomes and Cardioprotection - A Critical Analysis

Overview

Journal Mol Aspects Med

Specialties Biochemistry
Molecular Biology

Date 2017 Nov 11

PMID 29122678

Citations 53

Authors

Sean M Davidson

Derek M Yellon

Affiliations

Soon will be listed here.

Abstract

Exosomes are nano-sized vesicles released by numerous cell types that appear to have diverse beneficial effects on the injured heart. Studies using exosomes from stem cells or from the blood have indicated that they are able to protect the heart both in models of acute ischaemia and reperfusion, and during chronic ischaemia. In addition to decreasing initial infarct size, they are able to stimulate angiogenesis, reduce fibrosis and remodelling, alter immune cell function and improve long-term cardiac contractile function. However, since the technology and techniques used for the study of exosomes is relatively immature and continually evolving, there remain many important caveats to the interpretation of studies. This review presents a critical analysis of the field of exosomes and cardioprotection. We analyse the effects of exosomes from all types of stem cells investigated to date, summarize the major effects observed and their potential mechanism, and offer our perspective on the major outstanding issues.

Citing Articles

Angiogenesis after acute myocardial infarction: a bibliometric -based literature review.

Tan Y, Li M, Ma X, Shi D, Liu W Front Cardiovasc Med. 2025; 12:1426583.

PMID: 40017521 PMC: 11865093. DOI: 10.3389/fcvm.2025.1426583.

Potential of Exosomes as Multifunctional Nanocarriers for Targeted Drug Delivery.

Al-Ani S, Lee Q, Maheswaran D, Sin Y, Loh J, Foo J Mol Biotechnol. 2024; .

PMID: 39269575 DOI: 10.1007/s12033-024-01268-6.

Role of Exosomes in Cardiovascular Diseases.

Lin Q, He P, Tao J, Peng J Rev Cardiovasc Med. 2024; 25(6):222.

PMID: 39076309 PMC: 11270122. DOI: 10.31083/j.rcm2506222.

Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy.

Mao L, Liu S, Chen Y, Huang H, Ding F, Deng L Front Cardiovasc Med. 2024; 11:1399738.

PMID: 39006168 PMC: 11239395. DOI: 10.3389/fcvm.2024.1399738.

BMSC‑derived exosome‑mediated miR‑25‑3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‑like macrophage polarization.

Du J, Dong Y, Song J, Shui H, Xiao C, Hu Y Mol Med Rep. 2024; 30(2).

PMID: 38904206 PMC: 11208993. DOI: 10.3892/mmr.2024.13266.

References

Lawson C, Vicencio J, Yellon D, Davidson S . Microvesicles and exosomes: new players in metabolic and cardiovascular disease. J Endocrinol. 2016; 228(2):R57-71. DOI: 10.1530/JOE-15-0201. View

Takov K, Yellon D, Davidson S . Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes. J Extracell Vesicles. 2017; 6(1):1388731. PMC: 5699187. DOI: 10.1080/20013078.2017.1388731. View

Davidson S, Selvaraj P, He D, Boi-Doku C, Yellon R, Vicencio J . Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis. Basic Res Cardiol. 2013; 108(5):377. DOI: 10.1007/s00395-013-0377-6. View

Cheng K, Malliaras K, Ruckdeschel Smith R, Shen D, Sun B, Blusztajn A . Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair. JACC Heart Fail. 2014; 2(1):49-61. PMC: 3914736. DOI: 10.1016/j.jchf.2013.08.008. View

Lai C, Tannous B, Breakefield X . Noninvasive in vivo monitoring of extracellular vesicles. Methods Mol Biol. 2013; 1098:249-58. PMC: 5798617. DOI: 10.1007/978-1-62703-718-1_19. View

Takahashi Y, Nishikawa M, Shinotsuka H, Matsui Y, Ohara S, Imai T . Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013; 165(2):77-84. DOI: 10.1016/j.jbiotec.2013.03.013. View

Kim H, Choi D, Yun S, Choi S, Kang J, Jung J . Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2011; 11(2):839-49. DOI: 10.1021/pr200682z. View

Bell R, Botker H, Carr R, Davidson S, Downey J, Dutka D . 9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection. Basic Res Cardiol. 2016; 111(4):41. PMC: 4863033. DOI: 10.1007/s00395-016-0558-1. View

van der Pol E, Boing A, Gool E, Nieuwland R . Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost. 2015; 14(1):48-56. DOI: 10.1111/jth.13190. View

10.

Mayourian J, Cashman T, Ceholski D, Johnson B, Sachs D, Kaji D . Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity. Circ Res. 2017; 121(4):411-423. PMC: 5899516. DOI: 10.1161/CIRCRESAHA.117.310796. View

11.

Zhang Z, Yang J, Yan W, Li Y, Shen Z, Asahara T . Pretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial Repair. J Am Heart Assoc. 2016; 5(1). PMC: 4859399. DOI: 10.1161/JAHA.115.002856. View

12.

Lecour S, Botker H, Condorelli G, Davidson S, Garcia-Dorado D, Engel F . ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies. Cardiovasc Res. 2014; 104(3):399-411. PMC: 4242141. DOI: 10.1093/cvr/cvu225. View

13.

Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E . Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev. 2015; 24(14):1635-47. PMC: 4499790. DOI: 10.1089/scd.2014.0316. View

14.

Yellon D, Alkhulaifi A, Pugsley W . Preconditioning the human myocardium. Lancet. 1993; 342(8866):276-7. DOI: 10.1016/0140-6736(93)91819-8. View

15.

Paolini L, Zendrini A, Di Noto G, Busatto S, Lottini E, Radeghieri A . Residual matrix from different separation techniques impacts exosome biological activity. Sci Rep. 2016; 6:23550. PMC: 4806376. DOI: 10.1038/srep23550. View

16.

Eirin A, Zhu X, Puranik A, Woollard J, Tang H, Dasari S . Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells. PLoS One. 2017; 12(3):e0174303. PMC: 5363917. DOI: 10.1371/journal.pone.0174303. View

17.

Yuana Y, Levels J, Grootemaat A, Sturk A, Nieuwland R . Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles. 2014; 3. PMC: 4090368. DOI: 10.3402/jev.v3.23262. View

18.

Lai R, Tan S, Teh B, Sze S, Arslan F, de Kleijn D . Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome. Int J Proteomics. 2012; 2012:971907. PMC: 3407643. DOI: 10.1155/2012/971907. View

19.

Agarwal U, George A, Bhutani S, Ghosh-Choudhary S, Maxwell J, Brown M . Experimental, Systems, and Computational Approaches to Understanding the MicroRNA-Mediated Reparative Potential of Cardiac Progenitor Cell-Derived Exosomes From Pediatric Patients. Circ Res. 2016; 120(4):701-712. PMC: 5315680. DOI: 10.1161/CIRCRESAHA.116.309935. View

20.

Coumans F, Brisson A, Buzas E, Dignat-George F, Drees E, El-Andaloussi S . Methodological Guidelines to Study Extracellular Vesicles. Circ Res. 2017; 120(10):1632-1648. DOI: 10.1161/CIRCRESAHA.117.309417. View